Healthcare Sales & Marketing Network News: NGage

Searching News Database: NGage

HSMN NewsFeed - 16 Jul 2026
Pharmaceutical Brands Require Human Moderation on Social Media Far More Than Any Other Industry, New ICUC Report Finds
Biopharmaceuticals

HSMN NewsFeed - 9 Jul 2026
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2026
AbbVie Announces Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 May 2026
PainTEQ Launches TRAQ(TM), A Next-Generation Posterior Approach to SI Joint Fusion
Devices Neurosurgery Orthopaedic Product Launch

HSMN NewsFeed - 30 Apr 2026
Photon Raises $16M Series A to Give Patients Control Over Their Prescriptions and Bring Transparency to Pharmacy
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Apr 2026
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Mar 2026
ARTHEx Biotech Granted FDA Fast Track Designation for ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Jan 2026
Resolve M Therapeutics Exits From Stealth
Biopharmaceuticals

HSMN NewsFeed - 22 Oct 2025
Oticon Introduces the World's Smallest Powerhouse: Oticon Intent(TM) miniBTE R with Two Fitting Levels
Devices Product Launch

HSMN NewsFeed - 8 Jul 2025
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Jun 2025
Johnson & Johnson Launches VOLT(TM) Wrist and Proximal Humerus Plating Systems in the U.S.
Devices Orthopaedic Product Launch

HSMN NewsFeed - 16 Apr 2025
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Devices Orthopaedic Wound Care Venture Capital

HSMN NewsFeed - 5 Dec 2024
Sapience Therapeutics Strengthens Board of Directors and Management Team with Esteemed Business Development Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2024
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
Devices Orthopaedic Personnel

HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Mar 2024
Renibus Announces Leadership Transition
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2024
Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Nov 2023
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity(TM) Acute Infection and Sepsis Test System
Diagnostics FDA

HSMN NewsFeed - 19 Jul 2023
Velia Therapeutics Announces Appointment of Veteran Drug Developer, John McHutchison, AO, MD as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jul 2023
Renibus Therapeutics Announces $47 Million Financing to Advance Lead Program RBT-1 Through Pivotal Phase 3 Trial
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 31 Jan 2023
MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim
Devices Neurology Reimbursement

HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Devices Neurology FDA

HSMN NewsFeed - 12 Sep 2022
Haemonetics Earns CE Mark for VASCADE(R) Vascular Closure Product Portfolio
Devices Interventional Regulatory

HSMN NewsFeed - 24 Aug 2022
Plexium Strengthens Leadership Team with Appointment of Daniel Sipes as Senior Vice President, Head of Technology
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Aug 2022
Biotheryx Announces Appointment of Tracy Lawhon as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Aug 2022
Cardinal Health Announces Leadership Changes
Devices Biopharmaceuticals Distribution Personnel

HSMN NewsFeed - 7 Jul 2022
Biolase Announces Promotions of Key Team Members
Devices Dental Personnel

HSMN NewsFeed - 31 May 2022
Sapience Therapeutics Announces $41 Million Series B Financing to Advance Pipeline of Peptide Therapeutics Targeting Protein-Protein Interactions
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 May 2022
Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Mar 2022
Sapience Therapeutics Expands Executive Team with Appointment of Gina Capiaux, Ph.D. as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Mar 2022
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 23 Feb 2022
Plexium Announces $102M Financing To Advance Pipeline Of Targeted Protein Degradation Therapies And Technology Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 Jan 2022
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jan 2022
Smith & Nephew acquires novel cementless partial knee system
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 6 Dec 2021
Sapience Therapeutics Receives FDA Fast Track Designation for ST101 for the Treatment of Recurrent Glioblastoma Multiforme (GBM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Dec 2021
UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Nov 2021
FDA Authorizes PrecisionOS to Market VR Surgical Planning Tool
Devices Surgery FDA

HSMN NewsFeed - 22 Nov 2021
Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan(R)
Devices Gastroenterology Oncology

HSMN NewsFeed - 8 Nov 2021
Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Oct 2021
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Oct 2021
Accuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
Devices Oncology

HSMN NewsFeed - 7 Oct 2021
Tris Pharma(R) Hires Seasoned Business Development Executive
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 16 Sep 2021
LUMAKRAS(TM) (Sotorasib) Combined With Vectibix(R) (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 May 2021
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 May 2021
Genesis Software Innovations Announces FDA 510(k) Clearance For Preview(TM) 3D Shoulder Arthroplasty Planning Software
Devices Orthopaedic FDA

HSMN NewsFeed - 7 Apr 2021
MedShape Appoints Greg Berlet, MD as Chief Medical Officer
Devices Orthopaedic Personnel

HSMN NewsFeed - 23 Feb 2021
Elicio Therapeutics Announces FDA Clearance of IND application for ELI-002-- A Therapeutic Vaccine Targeting mutated KRAS Cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 3 Dec 2020
Neuroglee Therapeutics to Attack Alzheimer's Disease Through Personalized AI-Powered Digital Therapeutics
Devices Neurology Venture Capital

HSMN NewsFeed - 24 Nov 2020
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
Devices Cardiology Monitoring Venture Capital

HSMN NewsFeed - 9 Nov 2020
Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 6 Oct 2020
REYVOW(R) (lasmiditan) C-V Demonstrated Superior Pain Freedom At 2 Hours in At Least 2 of 3 Migraine Attacks in New Phase 3 Consistency of Effect Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Sep 2020
Prometheus Biosciences Appoints Olivier Laurent, Ph.D. as Chief Technology Officer
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 17 Sep 2020
Novo Ventures co-leads US $83m series C financing in Lava Therapeutics
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 11 Sep 2020
REYVOW(TM) (lasmiditan) C-V Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase 3 Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Sep 2020
Letter from Seneca Biopharma's Executive Chairman
Biopharmaceuticals

HSMN NewsFeed - 7 Aug 2020
Lodo Therapeutics Acquires Conifer Point Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 23 Jul 2020
Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Devices Neurology FDA

HSMN NewsFeed - 1 Jul 2020
Engage Surgical Announces FDA 510(k) Clearance And Limited Market Release Of The Cementless Engage(TM) Partial Knee System
Devices Orthopaedic FDA

HSMN NewsFeed - 5 Jun 2020
UCB Acquires Engage Therapeutics: Staccato(R) Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
Devices Drug Delivery Neurology Mergers & Acquisitions

HSMN NewsFeed - 2 Jun 2020
FDA Clears IND for iNKT Cells to Treat COVID-19 Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 26 May 2020
SMART Medical Systems Receives FDA Clearance for Its G-EYE(R) Colonoscope
Devices Gastroenterology Oncology FDA

HSMN NewsFeed - 21 May 2020
Varian Launches New Noona(R) Capabilities to Meet Growing Demand for Remote Cancer Patient Monitoring in Response to COVID-19's Impact on Healthcare
Devices Oncology Product Launch

HSMN NewsFeed - 12 May 2020
Travecta Therapeutics Secures $15 Million in Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 Mar 2020
Artio Medical Announces Interim Study Results Highlighting Aneurysm Occlusion Device at Neurovascular Conference
Devices Neurology Interventional

HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Mar 2020
Agenus Receives Fast Track Designation for Balstilimab & Zalifrelimab in Advanced Cervical Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 18 Feb 2020
Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
Devices Cardiology Regulatory Product Launch

HSMN NewsFeed - 27 Jan 2020
Ninety Percent of Patients Can't Use Inhalers Correctly, Digital Inhaler CapMedic Receives FDA Clearance to Change That
Devices Drug Delivery FDA

HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology

HSMN NewsFeed - 6 Nov 2019
Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Care
Devices Oncology

HSMN NewsFeed - 12 Aug 2019
Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2019
Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Biopharmaceuticals Reimbursement Litigation

HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 15 Apr 2019
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Mar 2019
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Biopharmaceuticals FDA Regulatory

HSMN NewsFeed - 12 Mar 2019
William T. Abraham, MD, joins V-Wave as Chief Medical Officer
Devices Cardiology Personnel

HSMN NewsFeed - 14 Feb 2019
Boehringer Ingelheim and Lilly announce the CAROLINA(R) cardiovascular outcome trial of Tradjenta(R) met its primary endpoint of non-inferiority compared with glimepiride
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 29 Jan 2019
ViaCyte Announces New Board Members
Regenerative Medicine Personnel

HSMN NewsFeed - 6 Dec 2018
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Nov 2018
A&D Medical Partners with HRS to Deliver Advanced Biometric Monitoring to Telehealth Patients
Devices Monitoring

HSMN NewsFeed - 25 Oct 2018
FogPharma Appoints Dr. Barbara Weber to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2018
Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
Devices Oncology Mergers & Acquisitions

HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 4 Oct 2018
Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 21 Sep 2018
CHMP Recommends Approval of Buvidal(R) (CAM2038) for the Treatment of Opioid Dependence
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Sep 2018
1st Wireless, Handheld, FDA-approved Ultrasound Device to Offer Live Demos at FMX (Family Medicine Experience) 2018, Booth #722
Devices Product Launch

HSMN NewsFeed - 28 Aug 2018
Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA(R) (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice
Biopharmaceuticals

HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 15 Aug 2018
Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals

HSMN NewsFeed - 19 Jul 2018
Olympus Appoints New Director of Medical and Surgical Business for the UK and Ireland
Devices Personnel

HSMN NewsFeed - 28 Jun 2018
Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR
Devices Interventional Cardiology Reimbursement

HSMN NewsFeed - 25 Jun 2018
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
Devices FDA

HSMN NewsFeed - 20 Jun 2018
Belmont Instrument, LLC Announces the Acquisition of MTRE Advanced Technologies Ltd.
Devices Mergers & Acquisitions

HSMN NewsFeed - 18 Jun 2018
Arcuro Medical Receives FDA Regulatory Clearance
Devices Orthopaedic FDA

HSMN NewsFeed - 24 May 2018
QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex
Devices Interventional Cardiology Acquisitions

HSMN NewsFeed - 16 May 2018
FogPharma Secures $66 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 7 May 2018
Varian Acquires Taiwan Distributor
Devices Oncology Distribution Mergers & Acquisitions

HSMN NewsFeed - 4 May 2018
Varian Notes Receipt of Competing Bid by Sirtex
Devices Oncology Mergers & Acquisitions

HSMN NewsFeed - 2 Apr 2018
Endo Agrees to Extend Temporary Stay of FDA Litigation
Biopharmaceuticals FDA Litigation

HSMN NewsFeed - 20 Mar 2018
Mark Stenhouse to join Exact Sciences as President, Cologuard
Diagnostics Oncology Personnel

HSMN NewsFeed - 9 Feb 2018
Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer's trials
Biopharmaceuticals Neurology

HSMN NewsFeed - 31 Jan 2018
Boehringer Ingelheim Announces Paul Fonteyne to Retire at the end of 2018. Wolfgang Baiker Appointed U.S. President & CEO Effective March 1, 2018
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2018
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Nov 2017
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
Regenerative Medicine FDA

HSMN NewsFeed - 16 Nov 2017
FDA Announces Comprehensive Regenerative Medicine Policy Framework
Regenerative Medicine FDA

HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces Series of Product Milestones and Launches Across Portfolio at American Academy of Ophthalmology 2017 Meeting
Devices Ophthalmology Product Launch

HSMN NewsFeed - 8 Nov 2017
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Oct 2017
Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 23 Oct 2017
Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.
Devices Monitoring Cardiology FDA Product Launch

HSMN NewsFeed - 18 Oct 2017
DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Jul 2017
eFFECTOR Therapeutics Completes $38.6 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 12 Jul 2017
Saebo Announces FDA Clearance of SaeboVR - World's First Virtual ADL Rehabilitation System
Devices Neurology FDA

HSMN NewsFeed - 9 Jun 2017
Zynex Hires Chief Financial Officer
Devices Neurology Personnel

HSMN NewsFeed - 22 May 2017
Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY(TM) (Romosozumab) In Postmenopausal Women With Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 11 May 2017
Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Apr 2017
Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch

HSMN NewsFeed - 16 Mar 2017
Upcoming National Healthcare CFO Summit 2017
Biopharmaceuticals

HSMN NewsFeed - 11 Mar 2017
Upcoming National Healthcare CFO Summit 2017
Biopharmaceuticals

HSMN NewsFeed - 2 Mar 2017
BLINCYTO(R) (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Feb 2017
FDA Expands Approval of SPIRIVA(R) RESPIMAT(R) (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Feb 2017
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 3 Feb 2017
NxStage Announces Appointment of Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 9 Jan 2017
The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Nov 2016
Hill-Rom Introduces Welch Allyn Home(TM) Hypertension Program
Devices Monitoring Cardiology Product Launch

HSMN NewsFeed - 31 Oct 2016
European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Biopharmaceuticals

HSMN NewsFeed - 21 Oct 2016
Medicrea Announces 2 FDA Clearances of New Specialized Components for Pediatric Deformity on PASS(R) and LigaPASS(R) Platforms for Complex Spine in Younger Patients
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 17 Oct 2016
Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox(R) for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 6 Oct 2016
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Sep 2016
Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy
Diagnostics Personnel

HSMN NewsFeed - 15 Sep 2016
Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin(R) (Daptomycin for Injection) in the United States
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 5 Sep 2016
New Data: STIOLTO(R) RESPIMAT(R) (tiotropium bromide+olodaterol) Inhalation Spray Significantly Improved Exercise Capacity in People with COPD
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 19 Aug 2016
Bayer and CRISPR Therapeutics joint venture, named Casebia Therapeutics, establishes operations in Cambridge, MA
Biopharmaceuticals

HSMN NewsFeed - 21 Jul 2016
LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical
Devices Monitoring Distribution

HSMN NewsFeed - 5 Jul 2016
Eagle Pharmaceuticals Announces Changes to Its Board of Directors; Director, Michael Graves Appointed Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 16 Jun 2016
Pernix Therapeutics Announces Positive Phase IV Results of Silenor(R) vs. Zolpidem Head-to-Head Arousability Study
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2016
Zynex Hires Vice President of Operations
Devices Personnel

HSMN NewsFeed - 2 May 2016
EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc(R) Neurometabolic Therapy to US Department of Veterans Affairs Medical Facilities
Devices Distribution

HSMN NewsFeed - 22 Apr 2016
Accuray Hosts Regional AERO Users' Meeting
Devices Oncology

HSMN NewsFeed - 4 Feb 2016
Phase 3 Study of BLINCYTO(R) (Blinatumomab) Met Primary Endpoint Of Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Jan 2016
Boehringer Ingelheim's Gilotrif(R) Demonstrated Superiority to Iressa(R) (Gefitinib) in Reducing the Risk of Disease Progression and Treatment Failure in First-Line Treatment of Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Jan 2016
Exact Sciences Announces Appointment of John A. Fallon, M.D., to Company's Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 16 Dec 2015
K2M Expands MIS Portfolio With Addition of Its EVEREST(R) Minimally Invasive XT Spinal System
Devices Orthopaedic Neurosurgery FDA Regulatory

HSMN NewsFeed - 9 Dec 2015
Flagship Ventures Launches Rubius To Develop Red-Cell Therapeutics(TM)
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Nov 2015
European Commission Approves Amgen's BLINCYTO(R) (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Nov 2015
Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Nov 2015
Cerapedics Receives FDA Approval for i-FACTOR(TM) Peptide Enhanced Bone Graft in Cervical Spine Surgery
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 23 Oct 2015
Physicians Interactive Advances Global Health Digital Engagement by Acquiring Univadis
Product Launch Acquisitions

HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Aug 2015
Jardiance(R) Demonstrated Cardiovascular (CV) Risk Reduction in People with Type 2 Diabetes at High Risk for CV Events
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 13 Aug 2015
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Aug 2015
NICE Recommends Once-daily Lixiana(R) (Edoxaban) for Preventing Stroke and Systemic Embolism in People with Non-valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 5 Aug 2015
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
Devices Cardiology Monitoring Personnel

HSMN NewsFeed - 9 Jul 2015
BioStar Ventures Raises $68.8 Million for Third Fund
Devices Cardiology Orthopaedic Venture Capital

HSMN NewsFeed - 16 Apr 2015
Sequana Medical signs collaboration agreement with Fresenius Medical Care for the marketing and distribution of the alfapump(R) system
Devices Distribution

HSMN NewsFeed - 1 Apr 2015
AMAG Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Feb 2015
Varian Medical Systems to Make Radiotherapy Available for More Cancer Patients in Africa
Devices Oncology

HSMN NewsFeed - 16 Dec 2014
Crescendo Biologics' Receives Further Investment from Astellas Venture Management to Develop Novel Humabody(TM) Therapeutics Targeting Immune Checkpoint Inhibitors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 Sep 2014
OnCore Biopharma Closes Series R Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Sep 2014
Geneia Inks Multi-Year Partnership with Covidien to Enter $21 Billion Remote Patient Monitoring Market
Devices Monitoring

HSMN NewsFeed - 6 Aug 2014
Akebia Therapeutics Announces Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2014
Zynex Announces Brian Alleman as Chief Financial Officer
Devices Neurology Personnel

HSMN NewsFeed - 25 Jun 2014
Zynex Appoints Director of Business Development
Devices Personnel

HSMN NewsFeed - 2 May 2014
Pfizer Confirms Delivery of Increased Proposal to AstraZeneca
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Apr 2014
Luoxis Obtains CE Marking for RedoxSYS(TM) Diagnostic System
Diagnostics Regulatory

HSMN NewsFeed - 31 Mar 2014
Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology

HSMN NewsFeed - 6 Mar 2014
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
Diagnostics Cardiology Product Launch

HSMN NewsFeed - 7 Jan 2014
Zynex Appoints Vice President of Sales for NeuroDiagnostics Division
Devices Neurology Personnel

HSMN NewsFeed - 31 Dec 2013
Miraculins and Cachet Pharmaceutical Agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DS(R) Diabetes Test in China
Diagnostics Endocrinology Licensing

HSMN NewsFeed - 23 Dec 2013
Blue Belt Technologies announces first Navio(TM) Unicondylar Knee Replacement performed in France
Devices Orthopaedic

HSMN NewsFeed - 12 Dec 2013
VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Nov 2013
Neovasc Reducer(TM) Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients with Refractory Angina
Devices Cardiology

HSMN NewsFeed - 9 Oct 2013
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
Devices Monitoring Cardiology Regulatory

HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Devices Otolaryngology

HSMN NewsFeed - 27 Sep 2013
Medtronic Gains Approval of First Artificial Pancreas Device System with Threshold Suspend Automation
Devices Drug Delivery FDA

HSMN NewsFeed - 9 Sep 2013
Intelomed Raises $4M with Series A-1 Round
Devices Venture Capital

HSMN NewsFeed - 6 Aug 2013
James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
Biopharmaceuticals Drug Delivery Ophthalmology Personnel

HSMN NewsFeed - 1 Aug 2013
Dicerna Secures $60 Million in Oversubscribed Series C Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 26 Jun 2013
VIVUS Announces SPEDRA (avanafil) Approval in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 May 2013
Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
Devices Interventional Cardiology

HSMN NewsFeed - 6 May 2013
Arrowhead Closes $36 Million Private Offering
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Apr 2013
Kevin M. Smith Appointed to Zynex Board of Directors
Devices Neurology Personnel

HSMN NewsFeed - 29 Apr 2013
ProUroCare Announces Changes to Management and Board of Directors
Devices Urology Personnel

HSMN NewsFeed - 15 Apr 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Apr 2013
InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
Devices Neurosurgery

HSMN NewsFeed - 28 Feb 2013
CooperSurgical Launches the New MityOne(R) Vacuum-Assisted Delivery System
Devices Ob/Gyn Product Launch

HSMN NewsFeed - 15 Feb 2013
Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2013
GSI Group to Acquire NDS Surgical Imaging for $82.5 Million
Devices Radiology Surgery Mergers & Acquisitions

HSMN NewsFeed - 28 Nov 2012
Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
Diagnostics Oncology

HSMN NewsFeed - 11 Oct 2012
Carl Zeiss Advances Surgical Visualization with New 3D HD Video System for the OPMI PENTERO Microscope
Devices Surgery

HSMN NewsFeed - 25 Sep 2012
Boehringer Ingelheim Expands Sales Force -- Adds 75 New Positions
Biopharmaceuticals Distribution

HSMN NewsFeed - 19 Sep 2012
Torax Medical Secures $30M Financing to Commercialize Pioneering Treatment for Reflux Disease
Devices Gastroenterology Venture Capital

HSMN NewsFeed - 5 Sep 2012
ImmuNext Enters into a Strategic Partnership with Janssen to Develop Novel Immunotherapies for the Treatment of Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Aug 2012
Zynex Receives FDA 510(k) Clearance for InWave Medical Device
Devices Urology FDA

HSMN NewsFeed - 11 Jun 2012
AliveCor Raises $10.5M in Series B Financing
Devices Monitoring Cardiology Venture Capital

HSMN NewsFeed - 1 Jun 2012
WebMD Appoints Pharmaceutical And Consumer Healthcare Industry Innovator Cavan M. Redmond As New CEO
Healthcare Information Personnel

HSMN NewsFeed - 7 May 2012
Kerberos to Sell FDA Cleared Rinspiration Technology
Devices Interventional Cardiology

HSMN NewsFeed - 10 Apr 2012
Vilex Introduces FUZE(TM) - TTC Arthrodesis Compression Nail
Devices Orthopaedic

HSMN NewsFeed - 12 Mar 2012
Zynex Acquires NeuroDyne Medical, Corp.
Devices Mergers & Acquisitions

HSMN NewsFeed - 26 Jan 2012
Amgen to Acquire Micromet
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 20 Jan 2012
Insmed Incorporated Provides Corporate Update
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2011
Torax Medical Receives CE Mark for the FENIX Continence Restoration System
Devices Regulatory

HSMN NewsFeed - 27 Oct 2011
Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2011
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
Devices Neurology FDA

HSMN NewsFeed - 19 Sep 2011
MAKO Surgical Corp. Introduces MAKOplasty(R) Total Hip Arthroplasty
Devices Orthopaedic

HSMN NewsFeed - 31 Aug 2011
Zynex Appoints Vice President of Reimbursement and Billing
Devices Personnel

HSMN NewsFeed - 2 May 2011
Medtronic Announces FDA Clearance and First Patient Procedure with the Achieve(TM) Mapping Catheter
Devices Cardiology FDA

HSMN NewsFeed - 25 Apr 2011
Visian(R) ICL and Toric ICL V4c Receive CE Mark Approval
Devices Ophthalmology Regulatory

HSMN NewsFeed - 22 Apr 2011
Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA(R) (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
Biopharmaceuticals Surgery Regulatory

HSMN NewsFeed - 18 Apr 2011
Ligand Names Matthew W. Foehr Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Mar 2011
Biothera Acquires MUC1 Anti-Cancer Monoclonal Antibody From Antisoma
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 23 Feb 2011
Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
Devices Interventional

HSMN NewsFeed - 22 Feb 2011
POZEN Announces Addition to Commercial Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Dec 2010
Zynex Strengthens Management Team; Adds Regulatory Compliance Expert
Devices Personnel

HSMN NewsFeed - 30 Nov 2010
Zynex, Inc. Appoints President of Subsidiary, Zynex NeuroDiagnostic
Devices Neurology Personnel

HSMN NewsFeed - 18 Nov 2010
Robert Cozart Promoted to VP of Technical Operations at Zynex
Devices Pain Management Personnel

HSMN NewsFeed - 3 Nov 2010
Questcor Pharmaceuticals Launches Acthar for the Treatment of Infantile Spasms
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Oct 2010
Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Sep 2010
Third Rock Ventures Raises $426 Million Fund II
Venture Capital Personnel

HSMN NewsFeed - 30 Aug 2010
Genzyme Confirms Receipt of Unsolicited Proposal
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Aug 2010
sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Aug 2010
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
Biopharmaceuticals

HSMN NewsFeed - 11 Aug 2010
Wound Management Technologies, Inc. Announces Business Expansion into South Africa with EWA Government Systems, Inc.
Devices Wound Care

HSMN NewsFeed - 27 Jul 2010
Titan Medical Inc. Announces MOU with Rochester General Hospital
Devices Surgery

HSMN NewsFeed - 21 Jul 2010
Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.
Biopharmaceuticals Diagnostics Distribution

HSMN NewsFeed - 15 Jul 2010
Provectus Pharmaceuticals Reports Achieved Milestones for First Half of 2010, Recent Developments and Plans for the Remainder of the Year to Shareholders
Biopharmaceuticals Dermatology Oncology

HSMN NewsFeed - 14 Jul 2010
Somaxon Pharmaceuticals Establishes Silenor Commercial Team
Biopharmaceuticals

HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2010
Cobalis Corp. Appoints Martin Marion as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2010
MitraClip Safely Relieves Symptoms in Patients With No Surgical Options
Devices Interventional Cardiology

HSMN NewsFeed - 12 Apr 2010
FORMA Therapeutics Appoints Robert Forrester Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2010
SpineAlign Medical Announces VerteLift, New Name for Innovative System for Vertebral Compression Fracture Treatment
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 11 Mar 2010
New Introducer Product Line from St. Jude Medical Offers Reliable Access and Facilitates Arterial Closure
Devices Interventional FDA Regulatory

HSMN NewsFeed - 1 Mar 2010
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Feb 2010
Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jan 2010
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Jan 2010
Natus Medical Announces Reorganization
Devices

HSMN NewsFeed - 11 Jan 2010
Viamet Pharmaceuticals Names William Moore, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2010
Acetylon Pharmaceuticals Tops Up Series A Financing with $2 Million Note And Appoints Simon Jones VP Biology and Preclinical Development and John van Duzer VP Chemistry and Manufacturing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 11 Sep 2009
PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009
Devices Interventional Cardiology

HSMN NewsFeed - 3 Sep 2009
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Sep 2009
Pfizer Concludes Previously Disclosed Settlement Agreement With U.S. Department Of Justice Regarding Past Promotional Practices
Biopharmaceuticals

HSMN NewsFeed - 25 Aug 2009
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jun 2009
Eli Lilly and Company Announces New Drug Discovery Initiative
Biopharmaceuticals Oncology Endocrinology

HSMN NewsFeed - 9 Jun 2009
Masimo Debuts New Rad-8(R) Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009
Devices Monitoring

HSMN NewsFeed - 13 May 2009
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 May 2009
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Biopharmaceuticals Diagnostics Monitoring Endocrinology

HSMN NewsFeed - 5 May 2009
Integra LifeSciences Launches Coral(TM) Extended Tab Spinal Screw Series
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 28 Apr 2009
Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2009
Lilly Names Susan Mahony Senior Vice President of Human Resources
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Apr 2009
PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Apr 2009
Medtronic Initiates Global Abdominal Aortic Aneurysm Study
Devices Interventional

HSMN NewsFeed - 27 Feb 2009
Astellas Commences Tender Offer to Acquire All Outstanding Shares of CV Therapeutics for $16.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Feb 2009
Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder
Devices Orthopaedic

HSMN NewsFeed - 23 Feb 2009
Genentech Special Committee Rejects Roche's $86.50 Offer as Inadequate
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Feb 2009
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Feb 2009
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation (DBS) Therapy for a Psychiatric Indication in the United States
Devices Neurology

HSMN NewsFeed - 18 Feb 2009
ArthroCare Announces Review of Insurance Billing Practices; CEO Departure and Management Changes; Investigations by SEC and US Attorney Offices in Florida and North Carolina
Devices Surgery Orthopaedic Personnel

HSMN NewsFeed - 27 Jan 2009
Astellas Proposes to Acquire CV Therapeutics for $16 per Share in Cash
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 29 Dec 2008
Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board
Devices Oncology Personnel

HSMN NewsFeed - 18 Nov 2008
Avalon Portfolio Urges TomoTherapy to Consider Strategic Alternatives, Including a Possible Sale
Devices Oncology

HSMN NewsFeed - 22 Oct 2008
Medtronic Submitted Pre-Market Approval Application For FDA Approval of InterStim(R) Therapy for Fecal Incontinence
Devices FDA

HSMN NewsFeed - 7 Oct 2008
Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc.
Devices Acquisitions

HSMN NewsFeed - 1 Oct 2008
TeleHealth Services’ Annual User Conference to Focus on Integrating Interactive Patient Care Technology into Hospital’s Quality, Service, and Workflow Initiatives
Devices

HSMN NewsFeed - 22 Sep 2008
Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Sep 2008
Bristol-Myers Squibb Submits Letter to ImClone Board of Directors
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jun 2008
Genzyme and Isis Complete Licensing of Mipomersen
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Jun 2008
PDI Announces Retirement of CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2008
Datascope to Explore Strategic Alternatives; Provides Financial Guidance for Continuing Operations
Devices Cardiology Monitoring

HSMN NewsFeed - 28 May 2008
Taro Terminates Merger Agreement with Sun Pharmaceutical Industries Ltd.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 May 2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
Biopharmaceuticals Wound Care

HSMN NewsFeed - 12 May 2008
LUNESTA(R) Study of Patients with Insomnia and Co-Morbid Generalized Anxiety Disorder (GAD) Published in Archives of General Psychiatry
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2008
Endourologists Now Have a New Category of Device For Stone Extraction to Help Render Patients Free from Kidney Stones and Stones in the Urinary Tract
Devices Urology

HSMN NewsFeed - 25 Apr 2008
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Apr 2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Biopharmaceuticals

HSMN NewsFeed - 17 Apr 2008
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
Merck Responds to Journal of the American Medical Association Articles
Biopharmaceuticals

HSMN NewsFeed - 12 Mar 2008
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Mar 2008
Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term
Orthopaedic

HSMN NewsFeed - 3 Mar 2008
Vasogen Provides Update on ACCLAIM II Program
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Feb 2008
Stiefel Laboratories, Inc. Appoints New President
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Feb 2008
Cleveland Clinic Collaborates with Google
Hospitals & Healthcare Systems

HSMN NewsFeed - 14 Feb 2008
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Feb 2008
AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
Devices Litigation

HSMN NewsFeed - 3 Jan 2008
Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Regenerative Medicine Urology

HSMN NewsFeed - 2 Jan 2008
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Biopharmaceuticals Distribution

HSMN NewsFeed - 17 Dec 2007
GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 31 Oct 2007
Biotech Veteran Joins AerovectRx as CEO
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 29 Oct 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 29 Oct 2007
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2007
Kensey Nash Reaches Agreement with Ramius on New Board Nominees
Devices Interventional Orthopaedic Personnel

HSMN NewsFeed - 24 Oct 2007
New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation
Devices Interventional Cardiology

HSMN NewsFeed - 15 Oct 2007
Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2007
Delcath Systems Issues CEO Letter to Shareholders
Devices Drug Delivery Oncology

HSMN NewsFeed - 27 Sep 2007
Adams Respiratory Therapeutics Files Lawsuit Against Perrigo for Infringement of Mucinex(R) Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 27 Sep 2007
Biomet Announces Resolution to Government Investigation
Devices Orthopaedic

HSMN NewsFeed - 26 Sep 2007
Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Biopharmaceuticals

HSMN NewsFeed - 15 Aug 2007
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 7 Aug 2007
KineMed and Merck Enter Collaboration in Atherosclerosis
Biopharmaceuticals

HSMN NewsFeed - 1 Aug 2007
InNexus Appoints FDA Expert Dr. Jur Strobos to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jul 2007
OmniGuide Announces CE Mark Approval of Flexible CO2 Laser Fibers
Devices Surgery Regulatory

HSMN NewsFeed - 11 Jul 2007
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 5 Jul 2007
Bausch & Lomb Receives Acquisition Proposal from Advanced Medical Optics for $75.00 Per Share in Cash and AMO Stock
Devices Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 25 Jun 2007
Roche Makes Offer to Acquire Ventana for $75.00 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 18 Jun 2007
Carl Zeiss Meditec Seeks Protection of Proprietary Information
Devices Litigation

HSMN NewsFeed - 31 May 2007
Dendreon Announces FDA Confirms Data Required for Provenge(R) Licensure
Biopharmaceuticals FDA

HSMN NewsFeed - 17 May 2007
Ablatherm-HIFU Adoption Growing Across Europe
Devices Oncology

HSMN NewsFeed - 17 May 2007
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 10 May 2007
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 9 May 2007
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 May 2007
Bayer HealthCare and Intendis Announce Strategic Alliance to Co-Promote Yaz(R) (Drospirenone/Ethinyl Estradiol) for Treatment of Moderate Acne
Biopharmaceuticals Dermatology

HSMN NewsFeed - 3 May 2007
Integrated BioPharma to Explore Divesting Its Biotechnology Business
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2007
Tri-anim Releases Remeex(TM) Needleless(TM) Sling System for Female Incontinence at ACOG
Devices Urology

HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 12 Apr 2007
Hill-Rom Names Richard Mussmann Vice President, Global Product Development & Chief Technology Officer
Devices Personnel

HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Apr 2007
Beckman Coulter Responds to Biosite Filing
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Apr 2007
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 9 Apr 2007
Biosite Fails to Respond to Inverness' Superior Proposal of $90.00 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 29 Mar 2007
BIO Provides Key Principles on Follow-On Biologics to Legislators
Biopharmaceuticals Generics

HSMN NewsFeed - 28 Mar 2007
Merck & Co., Inc. and Lundbeck Discontinue Joint Development Program for Gaboxadol, an Investigational Compound for Insomnia
Biopharmaceuticals

HSMN NewsFeed - 21 Mar 2007
Adams Respiratory Therapeutics Enters Into Settlement Agreement With Mutual Pharmaceutical
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 15 Mar 2007
Alexian Brothers Hospital Network To Bring Advanced Brain Mapping Technology To Chicagoland
Devices Neurology

HSMN NewsFeed - 28 Feb 2007
Vascular BioSciences Extends Patent Portfolio
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2007
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 22 Feb 2007
Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Feb 2007
Sepracor Announces Publication of Additional Data from Lunesta(R) Insomnia-Depression Study in the Journal of Clinical Sleep Medicine
Biopharmaceuticals

HSMN NewsFeed - 14 Feb 2007
Halozyme and Baxter Expand Global HYLENEX Collaboration
Biopharmaceuticals

HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Feb 2007
Orthovita Confirms That 510(k) Submission May Be Used to Seek Clearance for CORTOSS(R) Bone Augmentation Material for the Treatment of Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 1 Feb 2007
Fresenius Medical Care and Amgen Establish a Joint Research Program in Europe
Biopharmaceuticals

HSMN NewsFeed - 30 Jan 2007
Encore Therapeutics Inc. Reports Efficacy Data on a Long-Acting Local Anesthetic Drug
Biopharmaceuticals

HSMN NewsFeed - 22 Jan 2007
Pfizer Announces Priorities to Drive Improved Performance, Position Company for Future Success and Enhance Total Shareholder Return
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2007
Peregrine Pharmaceuticals' Tumor Necrosis Therapy Product for the Treatment of Lung Cancer Launched in China
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jan 2007
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2007
ThermoGenesis Corp. Appoints Industry Veteran William Osgood as General Manager of Operations
Devices Personnel

HSMN NewsFeed - 27 Dec 2006
Targacept to Receive $20 Million Milestone Payment as AstraZeneca Plans to Continue Development of AZD3480 (TC-1734)
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Dec 2006
Reliant Pharmaceuticals Files Patent Infringement Lawsuit Against Par Pharmaceutical
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Dec 2006
Statement from Eli Lilly and Company: Response to The New York Times Article from December 18, 2006
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2006
FDA Maintains Clinical Hold on VaxGen's Anthrax Vaccine Trial
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2006
Robert Brown Joins Biothera as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2006
Access Pharmaceuticals Receives MuGard(TM) Marketing Clearance From the FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2006
Results of Sepracor's LUNESTA(R) Next-Day Driving Study in Patients with Primary Insomnia Presented at American College of Neuropsychopharmacology Meeting
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2006
Data Show Sepracor's Lunesta(R) Improved Insomnia in Patients with Co-Existing Generalized Anxiety Disorder
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2006
LUNESTA(R) Perimenopause-Menopause Study Published in Journal of Obstetrics and Gynecology
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2006
Genzyme Begins Phase 2 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Nov 2006
Biomet Press Release
Devices Orthopaedic

HSMN NewsFeed - 12 Oct 2006
Newly Published Data Show Efficacy and Safety of LUNESTA(R) in Elderly Patients with Insomnia
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2006
Adams Respiratory Therapeutics Files Lawsuit Against Mutual Pharmaceuticals and United Research Laboratories for Infringement of Mucinex(R) Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 26 Sep 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Barr Laboratories Inc.
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 19 Sep 2006
Benefits of Vasomedical's EECP Therapy in Heart Failure Presented at the 10th Annual HFSA Scientific Meeting
Devices Cardiology

HSMN NewsFeed - 6 Sep 2006
Genzyme Begins Phase 3 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Sep 2006
Medtronic Announces the CD HORIZON(R) ENGAGE(TM) PLATE Spinal System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2006
Sepracor Announces Presentation of LUNESTA(TM) Data at Associated Professional Sleep Societies 20th Anniversary Meeting
Biopharmaceuticals

HSMN NewsFeed - 31 May 2006
IBM Collaborates With St. Jude Medical on New State-of-the-Art Cardiac Patient Care System
Devices Cardiology

HSMN NewsFeed - 31 May 2006
Cardiome Announces Refusal To File Decision By The FDA
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 16 May 2006
Valeant Pharmaceuticals Receives FDA Marketing Approval for Cannabinoid Cesamet(TM) (CII)
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 153

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 153 additional stories matching:
NGage
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!